,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,248,1,1,,442994,68288,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
1,608,1,6,,11536927,68288,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
2,1033,2,2,,11536927,68288,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
3,1549,1,2,,11536927,68288,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
4,1552,1,3,,11536927,68288,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
5,1637,1,2,,11536927,68288,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
6,1648,1,2,,11536927,68288,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
7,1259407,1,1,,363906643,68288,Active,,,,,CCRIS mutagenicity studies,Other,,
